Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Biobank Automation Systems Market Size And Revenue Outlook Through 2030
The biobank automation systems market has experienced strong growth in recent years. It is projected to increase from $2.03 billion in 2025 to $2.22 billion in 2026, at a compound annual growth rate (CAGR) of 9.7%. The historical expansion of this market can be attributed to factors such as the growth in biomedical research, increasing biobank sample volumes, the necessity for error reduction, the expansion of genomics studies, and the adoption of laboratory automation.
The biobank automation systems market is projected to experience substantial growth over the next few years. It is anticipated to expand to $3.19 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.4%. This projected growth can be attributed to several factors including the expansion of precision medicine, AI-driven sample management, global biobank collaborations, evolving regulatory compliance requirements, and the increasing demand for scalable storage solutions. Significant trends expected during this forecast period involve automated sample storage, robotic sample handling, high-throughput biobanking, digital sample traceability, and integrated biobank software systems.
Get A Free Sample Report With In-Depth Market Insights:
Biobank Automation Systems Market Demand Drivers Opening New Revenue Streams
The increasing occurrence of chronic illnesses is anticipated to boost the expansion of the biobank automation systems market in the future. These are enduring health issues, including conditions like diabetes, heart ailments, cancer, and long-term respiratory problems, which usually advance gradually and endure for extended periods, frequently necessitating continuous medical care. The heightened incidence of chronic diseases is primarily attributed to an aging global population, with a larger segment of individuals reaching older ages where illnesses such as cardiovascular disease, diabetes, and cancer are considerably more widespread. Biobank automation systems aid in managing the increasing burden of chronic diseases by facilitating dependable, extensive storage and swift recovery of patient biological samples for research, identifying biomarkers, and creating specific treatments. For example, in February 2024, the World Health Organization (WHO), a US-based health body, projected that worldwide cancer cases will surpass 35 million new instances by 2050, indicating a 77% increase compared to the estimated 20 million new cases documented in 2022. Consequently, the escalating occurrence of chronic diseases is propelling the biobank automation systems market.
Biobank Automation Systems Market Segmentation: How Does The Market Break Down By Category?
The biobank automation systems market covered in this report is segmented –
1) By Product Type: Automated Storage Systems, Automated Sample Preparation Systems, Automated Liquid Handling Systems, Other Product Types
2) By Application: Drug Discovery, Regenerative Medicine, Biobanking, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals, Other End-Users
Subsegments:
1) By Automated Storage Systems: Automated Ultra Low Temperature Freezer Systems, Automated Cryogenic Storage Systems, Automated High Density Biobanking Storage Systems, Automated Room Temperature Sample Storage Systems, Automated Tube And Vial Storage Systems
2) By Automated Sample Preparation Systems: Automated Nucleic Acid Extraction Systems, Automated Cell Preparation Systems, Automated Protein Purification Systems, Automated Histology And Tissue Processing Systems, Automated Sample Aliquoting Systems
3) By Automated Liquid Handling Systems: Automated Pipetting Workstation Systems, Automated Microplate Handling Systems, Automated Reagent Dispensing Systems, Automated Serial Dilution Systems, Automated Microplate Washing Systems
4) By Other Product Types: Automated Tube Decapping And Capping Systems, Barcode Labeling And Scanning Systems, Laboratory Information Management System Integration Modules, Environmental Monitoring And Control Systems, Robotic Laboratory Integration Platforms
Biobank Automation Systems Market Trends Powering Strategic Industry Growth
Major companies within the biobank automation systems market are concentrating on advanced innovations like eco-friendly cooling systems to boost energy efficiency, lessen their carbon footprint, and optimize large-scale sample storage operations. These sustainable cooling solutions represent sophisticated refrigeration technologies that utilize either natural air or refrigerants that do not deplete the ozone layer, thereby cutting down on power usage, lessening ecological harm, and promoting long-term ultracold storage practices. For example, in February 2024, Azenta, Inc., a US-based life sciences company, unveiled the BioArc Ultra, an innovative automated system designed for high-density and environmentally conscious ultracold sample management. The BioArc Ultra enables automated, space-efficient ultracold storage and recovery of samples, assisting biobanks in maximizing freezer utilization while preserving the reliability of stored samples. This system fosters more sustainable biobanking practices by incorporating an energy-saving design and environmentally benign refrigerants, consequently reducing the ecological impact associated with managing extensive sample collections. Its primary objective is to simplify intricate biorepository workflows, mitigate dangers from manual interventions, and ensure safe, trackable oversight of vital biological specimens for both research and medical applications.
Biobank Automation Systems Market Industry Leaders And Competitive Landscape
Major companies operating in the biobank automation systems market are Thermo Fisher Scientific Inc., Azenta Life Sciences, Sartorius AG, Becton Dickinson and Company, Tecan Group Ltd., Hamilton Company, Eppendorf SE, PHC Holdings Corporation, Haier Biomedical Co. Ltd., ASKION GmbH, LiCONiC AG, Micronic Holding B.V., Revvity Inc., Qiagen N.V., Greiner Bio-One International GmbH, BioLife Solutions Inc., LVL Technologies GmbH & Co. KG, RTS Life Science Ltd., Brooks Automation Inc., SP Scientific
View The Full Biobank Automation Systems Market Report:
Biobank Automation Systems Market Regional Analysis And Leading Geography
North America was the largest region in the biobank automation systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biobank automation systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
